Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	56,161	61,462	78,767	97,546	174,747	107,487
Market Cap Growth	-12.32%	-21.97%	-19.25%	-44.18%	62.58%	56.83%
Enterprise Value	38,484	39,202	46,863	48,995	136,075	93,693
Last Close Price	6510.00	7110.00	8862.64	10842.90	19192.91	11739.20
PE Ratio	35.34	21.09	-	9.60	11.21	21.97
PS Ratio	0.79	0.82	0.88	0.93	2.17	1.65
PB Ratio	0.66	0.71	0.92	1.10	2.28	1.75
P/TBV Ratio	0.68	0.74	0.96	1.17	2.36	1.82
P/FCF Ratio	-	-	-	-	21.89	32.74
P/OCF Ratio	-	-	84.64	-	19.60	29.17
EV/Sales Ratio	0.54	0.52	0.52	0.47	1.69	1.44
EV/EBITDA Ratio	37.15	16.92	12.39	4.80	14.51	14.52
EV/EBIT Ratio	-	41.15	18.79	5.33	18.26	20.96
EV/FCF Ratio	-14.25	-	-	-	17.04	28.54
Debt / Equity Ratio	0.11	0.04	0.08	0.20	0.21	0.01
Debt / EBITDA Ratio	9.01	1.59	1.78	1.74	1.68	0.12
Debt / FCF Ratio	-	-	-	-	1.97	0.23
Asset Turnover	0.66	0.70	0.72	0.77	0.75	0.82
Inventory Turnover	2.25	2.35	3.57	5.15	4.63	4.09
Quick Ratio	1.32	2.30	1.77	1.35	1.44	2.13
Current Ratio	2.51	4.39	2.60	1.88	1.77	3.06
Return on Equity (ROE)	2.51%	3.65%	-2.67%	12.78%	23.03%	7.83%
Return on Assets (ROA)	-0.16%	0.55%	1.25%	4.23%	4.34%	3.52%
Return on Capital (ROIC)	-0.19%	0.65%	1.57%	5.78%	6.03%	4.52%
Return on Capital Employed (ROCE)	-	1.10%	2.90%	10.30%	9.70%	6.90%
Earnings Yield	3.29%	4.74%	-0.15%	10.41%	8.92%	4.55%
FCF Yield	-4.81%	-7.58%	-0.02%	-4.94%	4.57%	3.05%
Dividend Yield	1.49%	1.37%	-	-	-	-
Payout Ratio	45.70%	28.70%	-	7.86%	4.93%	14.74%
Buyback Yield / Dilution	0.10%	0.50%	19.46%	-23.72%	0.07%	1.26%
Total Shareholder Return	1.58%	1.87%	19.46%	-23.72%	0.07%	1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.